Trial · NCT00094302
Results by group50
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 50
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Composite Outcome of Cardiovascular Mortality, Aborted Cardiac Arrest, or Hospitalization for the Management of Heart Failure, Whichever Occurred First | Placebo | 6.6 | Events per 100 person-years | ||
| Composite Outcome of Cardiovascular Mortality, Aborted Cardiac Arrest, or Hospitalization for the Management of Heart Failure, Whichever Occurred First | Spironolactone | 5.9 | Events per 100 person-years | ||
| Cardiovascular Mortality | Placebo | 3.1 | Events per 100 person-years | ||
| Cardiovascular Mortality | Spironolactone | 2.8 | Events per 100 person-years | ||
| Aborted Cardiac Arrest | Placebo | 0.09 | Events per 100 person-years | ||
| Aborted Cardiac Arrest | Spironolactone | 0.05 | Events per 100 person-years | ||
| Hospitalization for the Management of Heart Failure | Placebo | 4.6 | Events per 100 person-years | ||
| Hospitalization for the Management of Heart Failure | Spironolactone | 3.8 | Events per 100 person-years | ||
| All-cause Mortality | Placebo | 4.6 | Events per 100 person-years | ||
| All-cause Mortality | Spironolactone | 4.2 | Events per 100 person-years | ||
Composite Outcome of Cardiovascular Mortality or Cardiovascular-related Hospitalization (i.e., Hospitalization for Myocardial Infarction(MI), Stroke, or the Management of Heart Failure), Whichever Occurred First | Placebo | 7.8 | Events per 100 person-years | ||
Composite Outcome of Cardiovascular Mortality or Cardiovascular-related Hospitalization (i.e., Hospitalization for Myocardial Infarction(MI), Stroke, or the Management of Heart Failure), Whichever Occurred First | Spironolactone | 7.2 | Events per 100 person-years | ||
| Cardiovascular-related Hospitalization | Placebo | 6.2 | Events per 100 person-years | ||
| Cardiovascular-related Hospitalization | Spironolactone | 5.5 | Events per 100 person-years | ||
| Total Hospitalizations (Including Repeat Hospitalizations) for the Management of Heart Failure | Placebo | 8.3 | Events per 100 person-years | ||
| Total Hospitalizations (Including Repeat Hospitalizations) for the Management of Heart Failure | Spironolactone | 6.8 | Events per 100 person-years | ||
| Composite Outcome of Sudden Death or Aborted Cardiac Arrest, Whichever Occurred First | Placebo | 1.1 | Events per 100 person-years | ||
| Composite Outcome of Sudden Death or Aborted Cardiac Arrest, Whichever Occurred First | Spironolactone | 1.0 | Events per 100 person-years | ||
| New Onset Diabetes Mellitus, Among Subjects Without a History of Diabetes Mellitus at Baseline. | Placebo | 0.7 | Events per 100 person-years | ||
| New Onset Diabetes Mellitus, Among Subjects Without a History of Diabetes Mellitus at Baseline. | Spironolactone | 0.7 | Events per 100 person-years |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00094302/results